Beech Hill Advisors’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $5M | Sell |
22,975
-735
| -3% | -$163K | 2.5% | 5 |
|
|
2025
Q4 | $5.42M | Sell |
23,710
-512
| -2% | -$117K | 2.59% | 6 |
|
|
2025
Q3 | $5.61M | Sell |
24,222
-630
| -3% | -$128K | 2.62% | 8 |
|
|
2025
Q2 | $4.61M | Sell |
24,852
-2,291
| -8% | -$426K | 2.08% | 10 |
|
|
2025
Q1 | $5.69M | Sell |
27,143
-585
| -2% | -$114K | 2.26% | 8 |
|
|
2024
Q4 | $4.93M | Buy |
27,728
+217
| +0.8% | +$39.9K | 1.84% | 15 |
|
|
2024
Q3 | $5.43M | Sell |
27,511
-1,923
| -7% | -$359K | 2.06% | 12 |
|
|
2024
Q2 | $5.05M | Buy |
29,434
+27
| +0.1% | +$4.47K | 2.08% | 12 |
|
|
2024
Q1 | $5.36M | Buy |
29,407
+35
| +0.1% | +$6.03K | 2.23% | 11 |
|
|
2023
Q4 | $4.55M | Sell |
29,372
-2,540
| -8% | -$370K | 2.2% | 11 |
|
|
2023
Q3 | $4.76M | Sell |
31,912
-90
| -0.3% | -$13.2K | 2.4% | 9 |
|
|
2023
Q2 | $4.31M | Sell |
32,002
-25
| -0.1% | -$3.67K | 2.1% | 14 |
|
|
2023
Q1 | $5.1M | Sell |
32,027
-500
| -2% | -$76.4K | 2.57% | 7 |
|
|
2022
Q4 | $5.26M | Buy |
32,527
+363
| +1% | +$55.7K | 2.92% | 4 |
|
|
2022
Q3 | $4.32M | Buy |
32,164
+70
| +0.2% | +$10K | 2.47% | 8 |
|
|
2022
Q2 | $4.92M | Sell |
32,094
-321
| -1% | -$49K | 2.63% | 6 |
|
|
2022
Q1 | $5.25M | Sell |
32,415
-22,025
| -40% | -$3.2M | 2.14% | 13 |
|
|
2021
Q4 | $7.37M | Sell |
54,440
-924
| -2% | -$109K | 2.8% | 8 |
|
|
2021
Q3 | $5.97M | Buy |
55,364
+675
| +1% | +$77.1K | 2.48% | 12 |
|
|
2021
Q2 | $6.16M | Sell |
54,689
-730
| -1% | -$82.2K | 2.5% | 11 |
|
|
2021
Q1 | $6M | Sell |
55,419
-1,715
| -3% | -$183K | 2.49% | 13 |
|
|
2020
Q4 | $6.12M | Sell |
57,134
-2,110
| -4% | -$203K | 2.72% | 10 |
|
|
2020
Q3 | $5.19M | Sell |
59,244
-5,210
| -8% | -$491K | 2.56% | 12 |
|
|
2020
Q2 | $6.33M | Buy |
64,454
+6,080
| +10% | +$535K | 3.21% | 6 |
|
|
2020
Q1 | $4.45M | Buy |
58,374
+165
| +0.3% | +$14.1K | 3.04% | 9 |
|
|
2019
Q4 | $5.15M | Buy |
58,209
+225
| +0.4% | +$18.7K | 2.4% | 19 |
|
|
2019
Q3 | $4.39M | Buy |
57,984
+15,135
| +35% | +$1.04M | 2.35% | 20 |
|
|
2019
Q2 | $3.12M | Buy |
42,849
+2,325
| +6% | +$183K | 1.64% | 31 |
|
|
2019
Q1 | $3.27M | Buy |
40,524
+4,735
| +13% | +$387K | 2.01% | 26 |
|
|
2018
Q4 | $3.3M | Buy |
35,789
+22,400
| +167% | +$1.97M | 2.05% | 26 |
|
|
2018
Q3 | $1.27M | Buy |
13,389
+250
| +2% | +$23.7K | 0.66% | 40 |
|
|
2018
Q2 | $1.22M | Sell |
13,139
-42,443
| -76% | -$4.15M | 0.68% | 38 |
|
|
2018
Q1 | $5.26M | Buy |
55,582
+2,535
| +5% | +$278K | 2.77% | 14 |
|
|
2017
Q4 | $5.13M | Sell |
53,047
-29,420
| -36% | -$2.77M | 2.53% | 12 |
|
|
2017
Q3 | $7.33M | Buy |
82,467
+445
| +0.5% | +$33.9K | 3.87% | 3 |
|
|
2017
Q2 | $5.95M | Buy |
82,022
+890
| +1% | +$59.8K | 3.25% | 4 |
|
|
2017
Q1 | $5.29M | Sell |
81,132
-375
| -0.5% | -$23.6K | 3.04% | 4 |
|
|
2016
Q4 | $5.1M | Buy |
81,507
+3,610
| +5% | +$220K | 3.05% | 5 |
|
|
2016
Q3 | $4.91M | Buy |
77,897
+9,320
| +14% | +$603K | 3.01% | 10 |
|
|
2016
Q2 | $4.25M | Sell |
68,577
-2,060
| -3% | -$126K | 2.87% | 12 |
|
|
2016
Q1 | $4.04M | Buy |
70,637
+60
| +0.1% | +$3.34K | 3.16% | 13 |
|
|
2015
Q4 | $4.18M | Buy |
70,577
+1,735
| +3% | +$99.9K | 2.64% | 12 |
|
|
2015
Q3 | $3.75M | Sell |
68,842
-650
| -0.9% | -$42.3K | 2.39% | 14 |
|
|
2015
Q2 | $4.67M | Buy |
69,492
+2,475
| +4% | +$162K | 2.4% | 18 |
|
|
2015
Q1 | $3.92M | Buy |
67,017
+56,315
| +526% | +$3.4M | 1.84% | 22 |
|
|
2014
Q4 | $700K | Buy |
10,702
+350
| +3% | +$22.1K | 0.35% | 49 |
|
|
2014
Q3 | $598K | Buy |
10,352
+350
| +3% | +$19.4K | 0.28% | 66 |
|
|
2014
Q2 | $565K | Hold |
10,002
| – | – | 0.25% | 74 |
|
|
2014
Q1 | $514K | Buy |
10,002
+350
| +4% | +$17.7K | 0.24% | 85 |
|
|
2013
Q4 | $510K | Hold |
9,652
| – | – | 0.26% | 74 |
|
|
2013
Q3 | $432K | Hold |
9,652
| – | – | 0.23% | 79 |
|
|
2013
Q2 | $399K | Buy |
+9,652
| New | +$422K | 0.23% | 74 |
|
Other funds holding ABBV
VCM
VPM
Beech Hill Advisors's ABBV Position: Q1 2026 in Review
Beech Hill Advisors reduced its AbbVie (ABBV) stake by 3.1% in Q1 2026, selling an estimated $163K and leaving 22,975 shares worth $5M. The position accounts for 2.5% of the portfolio, ranked #5.
Beech Hill Advisors first reported a position in ABBV in Q2 2013 and has held it in 52 quarters since. The position peaked at $7.37M in Q4 2021. 4,075 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.
- Beech Hill Advisors held 22,975 shares of AbbVie worth $5M as of Q1 2026.
- Beech Hill Advisors sold 735 AbbVie shares in Q1 2026, an estimated $163K.
- AbbVie made up 2.5% of Beech Hill Advisors's portfolio in Q1 2026, its #5 holding.
- Beech Hill Advisors first reported a position in AbbVie in Q2 2013 and has held it in 52 quarters since.
- Beech Hill Advisors's AbbVie position peaked at $7.37M in Q4 2021.
- 4,075 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.
Based on Beech Hill Advisors's 13F filing for Q1 2026, filed 9 Apr 2026.